Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation

Journal of Neurochemistry

Volumn 118, Issue 2, 2011, Pages 237-247

  Li, Dongdong ^a   Herrera, Stacy ^a   Bubula, Nancy ^a   Nikitina, Elena ^a   Palmer, Abraham A ^a   Hanck, Dorothy A ^a   Loweth, Jessica A ^a   Vezina, Paul ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Department of Psychiatry and Behavioral Neuroscience ^*  (United States)

Author keywords

AMPA glutamate receptors; amphetamine; casein kinase 1; Darpp 32; dopamine; GluR1

Indexed keywords

4 [3 CYCLOHEXYL 5 (4 FLUOROPHENYL) 3H IMIDAZOL 4 YL]PYRIMIDIN 2 YLAMINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPA RECEPTOR; AMPHETAMINE; CASEIN KINASE IDELTA; CASEIN KINASE IEPSILON; GLUTAMATE RECEPTOR 1; GLUTAMIC ACID; PHOSPHOPROTEIN DARPP 32; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DENDRITIC SPINE; DRUG TARGETING; ENZYME INHIBITION; EVOKED CORTICAL RESPONSE; LOCOMOTION; MALE; MOTIVATION; NERVE CELL CULTURE; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

AMPHETAMINE; ANIMALS; CASEIN KINASE IDELTA; CASEIN KINASE IEPSILON; GLUTAMIC ACID; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHOSPHORYLATION; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 79960004376     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07308.x     Document Type: Article

References (48)

1. Anderson S. M., Famous K. R., Sadri-Vakili G., Kumaresan V., Schmidt H. D., Bass C. E., Terwilliger E. F., Cha J.-H. J., and, Pierce R. C., (2008) CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nature Neurosci. 11, 344-353. (Pubitemid 351311801)
2. Bachtell R. K., Choi K.-H., Simmons D. L., Falcon E., Monteggia L. M., Neve R. L., and, Self D. W., (2008) Role of GluR1 expression in the nucleus accumbens neurons in cocaine sensitization and cocaine-seeking behavior. Eur. J. Neurosci. 27, 2229-2240. (Pubitemid 351590908)
3. Badura L., Swanson T., Adamowicz W., et al. (2007) An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions. J. Pharmacol. Exp. Ther. 322, 730-738. (Pubitemid 47105782)
4. Banke T. G., Bowie D., Lee H.-K., Huganir R. L., Schousboe A., and, Traynelis S. F., (2000) Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J. Neurosci. 20, 89-102. (Pubitemid 30220495)
5. Beaulieu J.-M., Sotnikova T. D., Yao W.-D., Kockeritz L., Woodgett J. R., Gainetdinov R. R., and, Caron M. G., (2004) Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl Acad. Sci. USA 101, 5099-5104. (Pubitemid 38469209)
6. Bryant C. D., Graham M. E., Distler M. G., Munoz M. B., Li D., Vezina P., Sokoloff G., and, Palmer A. A., (2009) A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology 203, 703-711.
7. Chergui K., Svenningsson P., and, Greengard P., (2005) Physiological role for casein kinase 1 in glutamatergic synaptic transmission. J. Neurosci. 25, 6601-6609. (Pubitemid 40995292)
8. Desdouits F., Cohen D., Nairn A. C., Greengard P., and, Girault J.-A., (1995a) Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo. J. Biol. Chem. 270, 8772-8778.
9. Desdouits F., Siciliano J. C., Greengard P., and, Girault J.-A., (1995b) Dopamine- and cAMP-regulated phosphoprotein DARPP-32: Phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. Proc. Natl Acad. Sci. USA 92, 2682-2685.
10. Ehlers M. D., (2000) Reinsertion or degradation of AMPA receptors determined by activity-dependent endocytic sorting. Neuron 28, 511-525.
11. Esteban J. A., Shi S.-H., Wilson C., Nuriya M., Huganir R. L., and, Malinow R., (2003) PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity. Nature Neurosci. 6, 136-143. (Pubitemid 36182782)
12. Falcón E., and, McClung C. A., (2009) A role for circadian genes in drug addiction. Neuropharmacology 56, 91-96.
13. Fernandez E., Schiappa R., Girault J.-A., and, Le Novere N., (2006) DARPP-32 is a robust integrator of dopamine and glutamate signals. PloS Comp. Biol. 2, 1619-1633. (Pubitemid 46045174)
14. Fienberg A. A., Hiroi N., Mermelstein P. G., et al. (1998) Darpp-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838-842. (Pubitemid 28376047)
15. Gerfen C. R., Paletzki R., and, Worley P., (2008) Differences between dorsal and ventral striatum in Drd1a dopamine receptor coupling of dopamine- and cAMP-regulated phosphoprotein-32 to activation of extracellular signal-regulated kinase. J. Neurosci. 28, 7113-7120.
16. Greengard P., (2001) The neurobiology of slow synaptic transmission. Science 294, 1024-1030. (Pubitemid 33041850)
17. Hemmings H. C. Jr, Greengard P., Tung H. Y. L., and, Cohen P., (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310, 503-505. (Pubitemid 14052413)
18. Kamens H. M., Burkhart-Kasch S., McKinnon C. S., Li N., Reed C., and, Phillips T. J., (2005) Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav. 4, 110-125. (Pubitemid 40333315)
19. Knippschild U., Gocht A., Wolff S., Huber N., Löhler J., and, Stöter M., (2005) The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell. Signal. 17, 675-689. (Pubitemid 40250168)
20. Levran O., Londono D., O'Hara K., et al. (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav. 7, 720-729.
21. Liu F., Ma X.-H., Ule J., Bibb J. A., Nishi A., DeMaggio A. J., Yan Z., Nairn A. C., and, Greengard P., (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 98, 11062-11068. (Pubitemid 32928683)
22. Liu F., Virshup D. M., Nairn A. C., and, Greengard P., (2002) Mechanism of regulation of casein kinase 1 activity by group 1 metabotropic glutamate receptors. J. Biol. Chem. 277, 45393-45399. (Pubitemid 36159147)
23. Löhler J., Hirner H., Schmidt B., Kramer K., Fischer D., Thal D. R., Leithäuser F., and, Knippschild U., (2009) Immunohistochemical characterization of cell-type specific expression of CK1δ in various tissues of young adult BALB/c mice. PLoS ONE 4, 1-12.
24. 2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J. Neurosci. 30, 939-949.
25. Mangiavacchi S., and, Wolf M. E., (2004) D1 dopamine receptor stimulation increases the rate of AMPA receptor insertion onto the surface of cultured nucleus accumbens neurons through a pathway dependent on protein kinase A. J. Neurochem. 88, 1261-1271. (Pubitemid 38280694)
26. Meredith G. E., Pennartz C. M., and, Groenewegen H. J., (1993) The cellular framework for chemical signaling in the nucleus accumbens. Prog. Brain Res. 99, 3-24. (Pubitemid 24015883)
27. Nelson C. L., Milovanovic M., Wetter J. B., Ford K. A., and, Wolf M. E., (2009) Behavioral sensitization to amphetamine is not accompanied by changes in glutamate receptor surface expression in the rat nucleus accumbens. J. Neurochem. 109, 35-51.
28. Nikaido T., Akiyama M., Moriya T., and, Shibata S., (2001) Sensitized increase of Period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine. Mol. Pharmacol. 59, 894-900. (Pubitemid 32274019)
29. Oh M. C., Derkack V. A., Guire E. S., and, Soderling T. R., (2006) Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J. Biol. Chem. 281, 752-758.
30. Palmer A. A., Verbitsky M., Suresh R., et al. (2005) Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm. Genome 16, 291-305. (Pubitemid 41160333)
31. Paxinos G., and, Watson C., (1997) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic Press, New York.
32. Pellegrino L. L., Pellegrino A. S., and, Cushman A. J., (1979) A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York.
33. Pierce R. C., and, Kalivas P. W., (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25, 192-216. (Pubitemid 27501800)
34. Roche K. W., O'Brien R. J., Mammen A. L., Bernhardt J., and, Huganir R. L., (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16, 1179-1188. (Pubitemid 26227239)
35. Sesack S. R., Carr D. B., Omelchenko N., and, Pinto A., (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann. N Y Acad. Sci. 1003, 36-52. (Pubitemid 38083044)
36. Shi S.-H., Hayashi Y., Esteban J. A., and, Malinow R., (2001) Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105, 331-343. (Pubitemid 32455340)
37. Snyder G. L., Allen P. B., Fienberg A. A., Valle C. G., Huganir R. L., Nairn A. C., and, Greengard P., (2000) Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20, 4480-4488. (Pubitemid 30396613)
38. Sun X., Zhao Y., and, Wolf M. E., (2005) Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. J. Neurosci. 25, 7342-7351. (Pubitemid 41129806)
39. Surmeier D. J., Bargas J., Hemmings H. C. Jr, Nairn A. C., and, Greengard P., (1995) Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron 14, 385-397.
40. Svenningsson P., Tzavara E. T., Carruthers R., et al. (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302, 1412-1415. (Pubitemid 37452186)
41. Utz A. C., Hirner H., Blatz A., et al. (2010) Analysis of cell type-specific expression of CK1∈ in various tissues of young adult BALB/c mice and in mammary tumors of SV40 T-Ag-transgenic mice. J. Histochem. Cytochem. 58, 1-15.
42. D-amphetamine. Neuropsychopharmacology 31, 1056-1063.
43. Walton K. M., Fisher K., Rubitski D., et al. (2009) Selective inhibition of casein kinase 1∈ minimally alters circadian clock period. J. Pharmacol. Exp. Ther. 330, 430-439.
44. Wise R. A., and, Bozarth M. A., (1987) A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.
45. Wolf M. E., (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720. (Pubitemid 28137703)
46. Zachariou V., Benoit-Marand M., Allen P. B., Ingrassia P., Fienberg A. A., Ganon F., Greengard P., and, Picciotto M. R., (2002) Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors Darpp-32 or Inhibitor 1. Biol. Psychiatry 51, 612-620. (Pubitemid 34310498)
47. Zachariou V., Sgambato-Faure V., Sasaki T., Svenningsson P., Berton O., Fienberg A. A., Nairn A. C., Greengard P., and, Nestler E. J., (2006) Phosphorylation of Darpp-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology 31, 555-562. (Pubitemid 43276971)
48. Zhou M., Rebholz H., Brocia C., Warner-Schmidt J. L., Fienberg A. A., Nairn A. C., Greengard P., and, Flajolet M., (2010) Forebrain overexpression of CK1δ leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc. Natl Acad. Sci. USA 107, 4401-4406.